scispace - formally typeset
M

Masaaki Nakayama

Researcher at Tohoku University

Publications -  245
Citations -  8900

Masaaki Nakayama is an academic researcher from Tohoku University. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 40, co-authored 236 publications receiving 7811 citations. Previous affiliations of Masaaki Nakayama include Fukushima University & International University, Cambodia.

Papers
More filters
Journal ArticleDOI

Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the next-pd study

TL;DR: Use of the multidisciplinary approach described above reduces the risk of the development of EPS according to PD duration and can also attenuate the clinical course of the condition.
Journal ArticleDOI

A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial

TL;DR: Adding H(2) to haemodialysis solutions ameliorated inflammatory reactions and improved BP control and could offer a novel therapeutic option for control of uraemia.
Journal ArticleDOI

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

TL;DR: Whether febuxostat prevents the progression of renal disease and improves the prognosis of CKD is unclear, but it might have a renoprotective effect in hyperuricemic patients with CKD.
Journal ArticleDOI

Significance of screening for Fabry disease among male dialysis patients

TL;DR: A case of an atypical variant of Fabry among 450 male dialysis patients (0.22%) was found in the survey, indicating the potential for undiagnosed Fabry disease among Dialysis patients.
Journal ArticleDOI

Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.

TL;DR: It is demonstrated for the first time that an increased peritoneal solute transport rate (for both creatinine and β2-microglobulin) is associated with an increased surface area of peritoneAL microvessels, especially in patients on long-term PD treatment.